| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2366087A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | CA2366063A1 Translation regulation system and methods for use thereof |
| 09/14/2000 | CA2365968A1 Novel plant genes and uses thereof |
| 09/14/2000 | CA2365923A1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 09/14/2000 | CA2365904A1 Mitomycin biosynthetic gene cluster |
| 09/14/2000 | CA2365903A1 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 09/14/2000 | CA2365843A1 Expression of human alpha-fetoprotein in mammalian cells |
| 09/14/2000 | CA2365799A1 Cloning and expression of haemophilus somnus transferrin-binding proteins |
| 09/14/2000 | CA2364503A1 Compositions and methods for treating cancer and hyperproliferative disorders |
| 09/14/2000 | CA2364500A1 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 09/14/2000 | CA2363593A1 Nucleic acid respiratory syncytial virus vaccines |
| 09/14/2000 | CA2362885A1 Human kallikrein-like genes |
| 09/14/2000 | CA2362427A1 Compositions and methods for the treatment of immune related diseases |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2362370A1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/13/2000 | EP1035205A1 Non-spreading pestivirus |
| 09/13/2000 | EP1035204A1 Steroid hormone binding protein |
| 09/13/2000 | EP1035203A1 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants |
| 09/13/2000 | EP1035202A2 A cloning method for DNA fragments using arbitrarily primed PCR |
| 09/13/2000 | EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response |
| 09/13/2000 | EP1035129A1 A method of activating protein and an apparatus therefor |
| 09/13/2000 | EP1034795A2 Conjugates of lipids and biologically active compounds |
| 09/13/2000 | EP1034790A2 HIV therapy |
| 09/13/2000 | EP1034789A1 Type-2 chemokine binding proteins and methods of use therefor |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034296A1 ribH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 09/13/2000 | EP1034295A1 ribA |
| 09/13/2000 | EP1034289A1 Alphavirus vectors for paramyxovirus vaccines |
| 09/13/2000 | EP1034281A1 MAMMARY GLAND TISSUE-SPECIFIC EXPRESSION SYSTEM USING $G(b)-CASEIN PROMOTER SITE OF KOREAN NATIVE GOAT |
| 09/13/2000 | EP1034277A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/13/2000 | EP1034276A1 Novel era |
| 09/13/2000 | EP1034275A1 VACCINES FOR BLOCKING TRANSMISSION OF $i(PLASMODIUM VIVAX) |
| 09/13/2000 | EP1034274A2 Plant homologs of yeast pad1, yeast crm1, and human jab1: regulators of ap-1 type transcription factor activity |
| 09/13/2000 | EP1034273A1 Histamine and serotonin binding molecules |
| 09/13/2000 | EP1034272A1 A cDNA ENCODING C6 $g(b)-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN |
| 09/13/2000 | EP1034271A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1 |
| 09/13/2000 | EP1034270A1 Compositions and methods of use of het |
| 09/13/2000 | EP1034269A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
| 09/13/2000 | EP1034268A1 G-protein coupled receptors and uses therefor |
| 09/13/2000 | EP1034267A1 Compositions and methods for inducing gene expression |
| 09/13/2000 | EP1034266A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof |
| 09/13/2000 | EP1034265A1 Human cdc10 homolog |
| 09/13/2000 | EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening |
| 09/13/2000 | EP1034263A1 The nip3 family of proteins |
| 09/13/2000 | EP1034253A1 Gram negative coccoid bacterium |
| 09/13/2000 | EP1034252A2 Attenuated strains of mycobacteria |
| 09/13/2000 | EP1034188A1 Method of designing agonists and antagonists to igf receptor |
| 09/13/2000 | EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS |
| 09/13/2000 | EP1034186A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 09/13/2000 | EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3 |
| 09/13/2000 | EP1034184A2 Nuclear receptor ligands and ligand binding domains |
| 09/13/2000 | EP1034182A1 Inhibition of nuclear import by backbone cyclic peptide analogs |
| 09/13/2000 | EP1034004A1 Recombinant mycoplasma hyopneumoniae vaccine |
| 09/13/2000 | EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection |
| 09/13/2000 | EP1033997A1 Method of mobilizing hematopoietic stem cells |
| 09/13/2000 | EP1033996A1 Prevention and treatment of amyloidogenic disease |
| 09/13/2000 | EP1033953A1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 09/13/2000 | EP0957902A4 System for genetically treating cardiac conduction disturbances |
| 09/13/2000 | EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/13/2000 | EP0814834B1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same |
| 09/13/2000 | EP0772624B1 Interleukin-15 |
| 09/13/2000 | EP0759941B1 Heterodimer polypeptideimmunogen carrier composition and method for their use |
| 09/13/2000 | EP0733059B1 Compounds and methods for site-directed mutations in eukaryotic cells |
| 09/13/2000 | EP0641439B1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
| 09/13/2000 | EP0599935B1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 09/13/2000 | EP0571500B1 A high sulfur seed protein gene and method for increasing the sulfur amino acid content of plants |
| 09/13/2000 | EP0514488B1 Retinoid receptor compositions and methods |
| 09/13/2000 | CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response |
| 09/13/2000 | CN1266458A Novel DNA fragments ordering gene expression predominant in flower organ |
| 09/13/2000 | CN1266457A Mold-resistant plants and method of construction of same |
| 09/13/2000 | CN1266098A Growth mark regulated by growth hormone |
| 09/13/2000 | CN1266064A Vascalogenesis inhibition factor-endothelial inhibitor and preparation process thereof |
| 09/13/2000 | CN1265921A Erythropoiesis for treating anemia of family and raised animals |
| 09/13/2000 | CN1265891A Technoogies for producing inhibitant of tumor blood vessel formation |
| 09/13/2000 | CN1056383C Chinese trichosanthes protein, preparation method and use in pharmacy |
| 09/13/2000 | CN1056382C Improved HCV diagnostic agents |
| 09/12/2000 | US6118050 Nucleic acid which encodes polypeptide of defined amino acid sequence; transgenic cells and seeds; for screening herbicides |
| 09/12/2000 | US6118048 Trans-dominant inhibition of geminiviral DNA replication by geminivirus rep gene mutants |
| 09/12/2000 | US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents |
| 09/12/2000 | US6117990 Recombinant nucleic acid encoding a human g protein coupled receptor having a defined amino acid sequence; antiarthritic agents; anticarcinogenic/antidiabetic/antiepileptic agents; hypotensive/hypertensive agents; diagnosis of diseases |
| 09/12/2000 | US6117989 Human calcium-binding proteins |
| 09/12/2000 | US6117984 Growth hormone crystals and a process for production of these GH-crystals |
| 09/12/2000 | US6117983 Methods for purifying authentic IGF from yeast hosts |
| 09/12/2000 | US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening |
| 09/12/2000 | US6117977 Type C lectins |
| 09/12/2000 | US6117975 Amino acid and nucleotide sequences; for therapy |
| 09/12/2000 | US6117974 For screening bioactive molecules; compounds have n-alpha derivative amino acids linked by bridging group of disulfide, amide, thioether, thioester, imine, ether, or alkene to terminus located at a side chain or a backbone nitrogen |
| 09/12/2000 | US6117973 Peptide nucleic acid monomers; for use as probes to detect nucleic acids |
| 09/12/2000 | US6117848 Antisense oligonucleotide inhibition of ras |
| 09/12/2000 | US6117840 Inhibits binding between vla-4 receptor expressed on inflammatory leukocytes and fibronectin cs-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states |
| 09/12/2000 | US6117839 For increasing bone growth in mammals |
| 09/12/2000 | US6117837 Inhibiting proinflammatory cytokine production |
| 09/12/2000 | US6117836 Glycosylation-mediated inhibition of factor X |
| 09/12/2000 | US6117680 Compositions and methods for regulation of transcription |
| 09/12/2000 | US6117679 Adjusting polynucleotide sequences; amplifying nucleotide sequences and screening a recombinant polynucleotide for a desired property |
| 09/12/2000 | US6117673 Nucleotide sequence which codes for a protein associated signal tranduction; for diagnosis, treatment and preventing defects associated with signal transduction |
| 09/12/2000 | US6117670 Pyrrolnitrin biosynthesis genes and uses thereof |
| 09/12/2000 | US6117663 Crystal of a Ras-Sos complex |